Sign in

Filings

Finds words inside filing documents. Searching BIOFORCE NANOSCIENCES HOLDINGS, INC.'s filings · 20 documents indexed.

7 documents · 14 matches

  1. BFNH BIOFORCE NANOSCIENCES HOLDINGS, INC. 10-Q 2026-11-09

    Item 4. Controls and Procedures

    material weaknesses identified, determined that our internal control over financial reporting disclosure controls and procedures were not effective as of September
    2 matches in this document
  2. BFNH BIOFORCE NANOSCIENCES HOLDINGS, INC. 10-Q 2026-08-10

    Item 4. Controls and Procedures

    material weaknesses identified, determined that our internal control over financial reporting disclosure controls and procedures were not effective as of June
    2 matches in this document
  3. BFNH BIOFORCE NANOSCIENCES HOLDINGS, INC. 10-Q 2026-05-19

    Item 4. Controls and Procedures

    material weaknesses identified, determined that our internal control over financial reporting disclosure controls and procedures were not effective as of March
    2 matches in this document
  4. BFNH BIOFORCE NANOSCIENCES HOLDINGS, INC. 10-K 2026-04-15

    Item 9A. Controls and Procedures.

    material weaknesses identified, determined that our internal control over financial reporting disclosure controls and procedures were not effective as of December
    2 matches in this document
  5. BFNH BIOFORCE NANOSCIENCES HOLDINGS, INC. 10-Q 2025-11-19

    Item 4. Controls and Procedures

    material weaknesses identified, determined that our internal control over financial reporting disclosure controls and procedures were not effective as of September
    2 matches in this document
  6. BFNH BIOFORCE NANOSCIENCES HOLDINGS, INC. 10-Q 2025-08-11

    Item 4. Controls and Procedures

    material weaknesses identified, determined that our internal control over financial reporting disclosure controls and procedures were not effective as of June
    2 matches in this document
  7. BFNH BIOFORCE NANOSCIENCES HOLDINGS, INC. 10-Q 2025-05-13

    Item 4. Controls and Procedures

    material weaknesses identified, determined that our internal control over financial reporting disclosure controls and procedures were not effective as of March
    2 matches in this document

Page 1 of 1 · 7 documents